Effects of blood transportation on human peripheral mononuclear cell yield, phenotype and function: Implications for immune cell biobanking

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Posevitz Fejfár, Anita ^a   Posevitz, Vilmos ^a   Gross, Catharina C ^a   Bhatia, Urvashi ^a   Kurth, Frank ^a   Schütte, Verena ^a   Bar Or, Amit ^b   Meuth, Sven G ^a   Wiendl, Heinz ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 22; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 9; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ADULT; ARTICLE; B LYMPHOCYTE; BIOBANKING; BLOOD SAMPLING; BLOOD TRANSPORTATION; CELL FUNCTION; CELL ISOLATION; CELL VIABILITY; CLINICAL LABORATORY; CONTROLLED STUDY; CRYOPRESERVATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; LYMPHOCYTE PROLIFERATION; MALE; MEDICAL PROCEDURES; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; SHIPPING; SIGNAL TRANSDUCTION; STANDARDIZATION; T LYMPHOCYTE SUBPOPULATION; TRAFFIC AND TRANSPORT; BLOOD BANK; BLOOD STORAGE; CELL PROLIFERATION; CYTOLOGY; IMMUNOLOGY; MIDDLE AGED; MONONUCLEAR CELL;

ADULT; BLOOD BANKS; BLOOD PRESERVATION; BLOOD SPECIMEN COLLECTION; CELL PROLIFERATION; CRYOPRESERVATION; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; SIGNAL TRANSDUCTION;

EID: 84919903199     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115920     Document Type: Article

References (27)

1. Betensky RA, Connick E, Devers J, Landay AL, Nokta M, et al. (2000) Shipment impairs lymphocyte proliferative responses to microbial antigens. Clin Diagn Lab Immunol 7:759-763.
2. Bull M, Lee D, Stucky J, Chiu YL, Rubin A, et al. (2007) Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials. J Immunol Methods 322:57-69.
3. Costantini A, Mancini S, Giuliodoro S, Butini L, Regnery CM, et al. (2003) Effects of cryopreservation on lymphocyte immunophenotype and function. J Immunol Methods 278:145-155.
4. Jeurink PV, Vissers YM, Rappard B, Savelkoul HF (2008) Tcell responses in fresh and cryopreserved peripheral blood mononuclear cells: kinetics of cell viability, cellular subsets, proliferation, and cytokine production. Cryobiology 57:91-103.
5. Kleeberger CA, Lyles RH, Margolick JB, Rinaldo CR, Phair JP, et al. (1999) Viability and recovery of peripheral blood mononuclear cells cryopreserved for up to 12 years in a multicenter study. Clin Diagn Lab Immunol 6:14-19.
6. Kreher CR, Dittrich MT, Guerkov R, Boehm BO, Tary-Lehman. (2003) CD4+ and CD8+ cells in cryopreserved human PBMC maintain full functionality in cytokine ELISPOTassays. J Immunol Methods 278:79-93.
7. Kutscher S, Dembek CJ, Deckert S, Russo C, Korber N, et al. (2013) Overnight resting of PBMC changes functional signatures of antigen specific T-cell responses: impact for immune monitoring within clinical trials. PLoS One 8:e76215.
8. Naranbhai V, Bartman P, Ndlovu D, Ramkalawon P, Ndung'u T, et al. (2011) Impact of blood processing variations on natural killer cell frequency, activation, chemokine receptor expression and function. J Immunol Methods 366:28-35.
9. Olson WC, Smolkin ME, Farris EM, Fink RJ, Czarkowski AR, et al. (2011) Shipping blood to a central laboratory in multicenter clinical trials: effect of ambient temperature on specimen temperature, and effects of temperature on mononuclear cell yield, viability and immunologic function. J Transl Med 9:26.
10. Owen RE, Sinclair E, Emu B, Heitman JW, Hirschkorn DF, et al. (2007) Loss of T cell responses following long-term cryopreservation. J Immunol Methods 326:93-115.
11. Reimann KA, Chernoff M, Wilkening CL, Nickerson CE, Landay AL (2000) Preservation of lymphocyte immunophenotype and proliferative responses in cryopreserved peripheral blood mononuclear cells from human immunodeficiency virus type 1-infected donors: implications for multicenter clinical trials. The ACTG Immunology Advanced Technology Laboratories. Clin Diagn Lab Immunol 7:352-359.
12. Weinberg A, Song LY, Wilkening C, Sevin A, Blais B, et al. (2009) Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization. Clin Vaccine Immunol 16:1176-1186.
13. Weinberg A, Zhang L, Brown D, Erice A, Polsky B, et al. (2000) Viability and functional activity of cryopreserved mononuclear cells. Clin Diagn Lab Immunol 7:714-716.
14. Germann A, Schulz JC, Kemp-Kamke B, Zimmermann H, von Briese. (2011) Standardized Serum-Free Cryomedia Maintain Peripheral Blood Mononuclear Cell Viability, Recovery, and Antigen-Specific T-Cell Response Compared to Fetal Calf Serum-Based Medium. Biopreserv Biobank 9:229-236.
15. McKenna KC, Beatty KM, Vicetti Miguel R, Bilonick RA (2009) Delayed processing of blood increases the frequency of activated CD11b+ CD15+ granulocytes which inhibit Tcell function. J Immunol Methods 341:68-75.
16. Olemukan RE, Eller LA, Ouma BJ, Etonu B, Erima S, et al. (2010) Quality monitoring of HIV-1-infected and uninfected peripheral blood mononuclear cell samples in a resource-limited setting. Clin Vaccine Immunol 17:910-918.
17. Posevitz V, Arndt B, Krieger T, Warnecke N, Schraven B, et al. (2008) Regulation of T cell homeostasis by the transmembrane adaptor protein SIT. J Immunol 180:1634-1642.
18. Posevitz-Fejfar A, Smida M, Kliche S, Hartig R, Schraven B, et al. (2008) A displaced PAG enhances proximal signaling and SDF-1-induced T cell migration. Eur J Immunol 38:250-259.
19. Duggleby RC, Shaw TN, Jarvis LB, Kaur G, Gaston JS (2007) CD27 expression discriminates between regulatory and non-regulatory cells after expansion of human peripheral blood CD4+ CD25+ cells. Immunology 121:129-139.
20. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, et al. (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 203:1701-1711.
21. Ruprecht CR, Gattorno M, Ferlito F, Gregorio A, Martini A, et al. (2005) Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. J Exp Med 201:1793-1803.
22. Kimura A, Kishimot. (2010) IL-6: regulator of Treg/Th17 balance. Eur J Immunol 40:1830-1835.
23. Pantaleo G, Harar. (2006) Functional signatures in antiviral T-cell immunity for monitoring virusassociated diseases. Nat Rev Immunol 6:417-423.
24. Maecker HT, Moon J, Bhatia S, Ghanekar SA, Maino VC, et al. (2005) Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT. BMC Immunol 6:17.
25. Neurath MF, Finott. (2011) IL-6 signaling in autoimmunity, chronic inflammation and inflammationassociated cancer. Cytokine Growth Factor Rev 22:83-89.
26. Schmielau J, Finn OJ (2001) Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. Cancer Res 61:4756-4760.
27. Zea AH, Rodriguez PC, Atkins MB, Hernandez C, Signoretti S, et al. (2005) Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res 65:3044-3048.